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Biomechanical assessment of the longitudinal compression behavior of drug eluting coronary stents: an in vitro comparative study Background: Significant longitudinal compression has been clinically observed in cases where drug-eluting coronary stents were crossed by other interventional devices. Our objective was to characterize stent longitudinal resistance under simulated clinical worst case crossing scenarios in good apposition and malapposition in-vitro models. Methods: 6 commercially available coronary balloon-expandable stent designs were evaluated. First direct parallel plates longitudinal crush resistance was conducted after deploying 3 samples/design to 3 mm diameter. Then 12 samples/design were tracked over a 0.014Љ interventional guidewire, positioned and deployed in either good apposition or malapposition coronary vessel models, 6 samples each, respectively. After deployment and withdrawal of the balloon, a new balloon was advanced over the guidewire automatically using the IDTE 2000 (Interventional Device Testing Equipment, Machine Solutions, Inc, Flagstaff, AZ, USA). For each sample, the force required to track the balloon through the stent and the change in stent length after balloon crossing were both calculated. Results: In the parallel plate crush test, 3 out of 6 stent designs demonstrated higher longitudinal crush rates compared to the Resolute, Medtronic, Minneapolis USA (Promus Element, Boston Scientific Corp., Natik USA & Coroflex Blue, BBraun, Melsungen Germany, pϽ0.001; Orsiro, Biotronik, Berlin Germany, pϭ0.038). In the simulated use test, longitudinal crush ranged from 5 to 22%; however, no statistically significant differences in longitudinal crush were seen between stent types for both good apposition (pϭ0.836) and malapposition cases (pϭ0.447). One stent type showed significantly higher longitudinal crush (pϭ0.027) in the malapposed model compared to the good apposition model. Conclusions: Lower resistance to pure mechanical longitudinal crush of some stent designs seen in bench testing did not correlate to significantly higher crush rates in good simulated clinical conditions. Nevertheless, it would be useful to take account the rough mechanical characteristics of some new stents to minimize longitudinal compression during stent implantation. Background: Stent fracture (SF) has been frequently reported in clinical trials and it has been associated with restenosis and thrombosis. In this study we aimed to determine the predictors of stent fracture by using a single stent design in the porcine coronary model. Methods: A total of 113 Cypher stents were implanted in normal coronary arteries at a 10% overstretch ratio in a single (81.4%), overlapping (30.6%) or T-bifurcation (19.4%) stent configuration. At termination, we reviewed high-contrast film-based radiographs to examine for the presence of SF. SF was graded as minor (Ͻ2 SF), multiple (Ն2 SF) and major (multiple SF with complete transection or SF at multiple sites). Angiographic and histo-morphometric data were compared between groups with SF and without SF (non-SF). Results: SF was found in 11 stents (9.5%; minor ϭ 3(27.3%), multiple ϭ 3(27.3%), and major ϭ 5(45.5%)). SF was more commonly seen in longer stents (SFϭ 19.9Ϯ4.8 mm versus non-SFϭ 14.3Ϯ3.2 mm, pϽ0.001), T-bifurcation location (SF: 68.8% versus non-SF: 10.9%, pϽ0.001) and overlapping stents (SF: 75.0% versus non-SF: 22.8%, pϽ0.001). Angiographic restenosis (Ͼ50%) was higher in the SF (33.3%) group compared to non-SF (4.3%, pϭ0.016) and it was found only on the multiple (1 of 3) or major (2 of 5) SF groups. [5.44, 391 .72], pϽ0.001) were identified as independent predictors of SF. Conclusions: At the experimental setting, the incidence of SF found was high. Specific technical situations (i.e., overlapping stents) were predictors of SF and were associated to higher degrees of neointimal proliferation. SF may be a strong contributor of stent failure in complex technical situations. 
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Predictors of Stent Fracture and Impact on Neointimal Proliferation: Experimental Insights into the Mechanisms of Drug Eluting Stent Failure
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